FREDERICK, Md., Sept. 29, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced another key expansion in its commercial strategy with the adoption of SteraMist iHP technology by Steri-Clean , a premier provider of hoarding cleanup and biohazard remediation services. This development underscores TOMI's targeted push to onboard larger franchised groups as service providers, enhancing a scalable network growth while tackling escalating public health issues across the United States.

Steri-Clean specializes in compassionate hoarding cleanup, crime scene remediation, and biohazard decontamination with approximately 60 franchises. The company has built a reputation for handling complex, sensitive cleaning scenarios, including those involving severe clutter, mold infestations, and hazardous materials. The Company is led by President Corey Chalmers, renowned Host & Expert Cleaner on A&E's hit series "Hoarders." With over 30 years of experience in extreme cleaning and a platform reaching millions through television, Chalmers has championed the integration of advanced technologies like SteraMist to elevate industry standards and improve outcomes for clients facing hoarding challenges.

Steri-Clean has implemented two SteraPak units—portable, backpack-style systems designed for efficient, on-site decontamination—across two of its franchise locations. This initial rollout positions Steri-Clean to enhance its service offerings, delivering faster, more effective disinfection without corrosive residues or downtime. TOMI anticipates further expansion within Steri-Clean's network, driven by the technology's proven effectiveness in infection control against pathogens like MRSA, C. diff, Norovirus, and COVID, and its critical role in disinfecting death and trauma scenes.

"As the host of 'Hoarders' and leader of Steri-Clean, I've seen firsthand the devastating biohazard risks in hoarding environments and other situations where infectious contaminants spread," said Cory Chalmers, President of Steri-Clean. "Adopting SteraMist iHP technology will transform our ability to provide safe, thorough cleanups. We're eager to expand its use across our franchises, driving better results for clients and setting new benchmarks in the industry."

Dr. Halden S. Shane, TOMI’s CEO commented, “This alliance aligns with TOMI's broader commercial strategy, which includes recent initiatives like the SteraMist Pro Certified educational platform and an expanded customer support team. As franchised networks like Steri-Clean scale SteraMist adoption, TOMI is well-equipped to capitalize on emerging U.S. challenges, including infectious disease outbreaks, crime scene cleanups, and the complex biohazards often found in hoarding situations.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at [email protected] .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to the ability of TOMI to enhance and grow its customers and address emerging public health issues. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
[email protected]